Research Accelerated by You Lupus Registry
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- Lupus Foundation of America
- Study ID
- NCT06927219
- Status
- Recruiting
Conditions
- Cutaneous Lupus Erythematosus (CLE)
- Lupus Nephritis (LN)
- Systemic Lupus Erythematosus (SLE)
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
Summary The Lupus Foundation of America (LFA) Research Accelerated by You (RAY) Registry is a fully remote, longitudinal registry designed to collect data from adults and children living with lupus. The primary goal is to better understand the diagnosis, treatment, care, and quality of life for those affected by the disease. Remote Participation This is a decentralized, online-only registry. Participation is conducted entirely through a secure web-based portal. There are no physical site visits or travel requirements; participants can contribute from any location with internet access. Participation Details Consent: Informed consent is completed electronically. Surveys: Participants complete electronic surveys upon enrollment and every six months thereafter. Data Types: Collected data is self-reported and includes demographics, diagnosis history, treatment information, and patient-reported outcomes (PROs), such as quality of life. Purpose and Data Use The LFA uses registry data to: Address Constituent Needs: Inform programs and resources for the lupus community. Advance Research: Share patient insights with to ensure therapies are developed with the consideration of what matters and what matters most to people living with lupus. Patient Engagement and Clinical Research Matching: Participants may be contacted to assess eligibility for patient engagement or clinical research opportunities or to complete specific sub-surveys regarding trial participation.
Key Dates
- Start date
- Oct 1, 2020
- Status verified
- Jan 2026
- Primary completion
- Sep 30, 2030
- Completion
- Dec 31, 2050
Study Design
- Enrollment
- 10,000 participants (estimated)
Arms
- Arm: Lupus PatientsThis is an observational study of people living with systemic lupus erythematosus, lupus nephritis, cutaneous lupus erythematosus or a mixture of these diseases
Primary Outcome Measure
Functional Assessment of Chronic Illness Therapy-Fatigue Scale [ Time Frame: Over a 10 year period ]
Central Contacts
- Joy N Buie, PhD, MSCR, BSN202-924-4818
- Daniel McSkimming, PhD202-349-1155
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Online Registry - No Physical Site Required | Washington D.C. | District of Columbia | 20037 | - |
Find similar trials in Washington D.C., DC
Related Studies
- An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus ErythematosusPHASE3 · Enrolling By Invitation · Biogen · Phoenix, Arizona
- Lupus Landmark Study: A Prospective Registry and BiorepositoryRecruiting · Lupus Research Alliance · Birmingham, Alabama
- Prevalence and Clinical Severity of Cutaneous Lupus ErythematosusRecruiting · University of Pennsylvania · Philadelphia, Pennsylvania
- Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by QuestionnairesRecruiting · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · Bethesda, Maryland